Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Duliang
- Development stage
- Unknown
- Lead developer
- Chinese PLA General Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Duliang is a Traditional Chinese Medicine (TCM) formulation primarily used for the treatment of various types of headaches, including chronic daily headache, migraine, and tension-type headache. The formulation typically consists of two main herbal components: *Angelica dahurica* (Baizhi) and *Ligusticum chuanxiong* (Chuanxiong). According to TCM principles, it is designed to expel wind, resolve the exterior, and alleviate pain. Pharmacologically, Duliang is thought to exert analgesic and anti-inflammatory effects, potentially by modulating cerebral blood flow and neurotransmitters associated with pain signaling. It is commonly administered as a soft capsule and has been evaluated in clinical trials for its efficacy and safety in chronic headache management.
- Brand names
- Duliang soft capsuleDuliang Wan
- Other names
- Duliang capsule
Beyond the preview
Go deeper on Duliang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Duliang.